Hepatic Arterial Infusion Chemotherapy with Cisplatin versus Sorafenib for Intrahepatic Advanced Hepatocellular Carcinoma: A Propensity Score-Matched Analysis
Yuki Zaizen(Kurume University), Takuji Torimura(Omuta hospital), Kotaro Kuwaki(Kurume University), Masahito Nakano(Kurume University), Hironori Koga(Kurume University), Kazuta Fukumori(Kurume University), Sohei Yoshimura(Kurume University), Naoki Kamachi(Kurume University), Shigeo Shimose(Kurume University), Masaru Fukahori(Kurume University), Yoichi Yano, Hideki Iwamoto, Ryoko Kuromatsu(Kurume University), Mika Nakazaki(Kurume University), Takashi Niizeki(Kurume University), Takahiko Sakaue(Kurume University), Shusuke Okamura(Kurume University), Yu Noda(Kurume University), Kota Takaki, Tomotake Shirono(Kurume University)
Cited by 16
Related Papers
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
|Journal of Hepatology|2016|504
MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
|Liver International|2020|410